Therapeutic potential of phytochemicals for cystic fibrosis

被引:4
|
作者
Baharara, Hamed [1 ]
Kesharwani, Prashant [2 ,3 ]
Johnston, Thomas P. [4 ]
Sahebkar, AmirHossein [5 ,6 ,7 ]
机构
[1] Mashhad Univ Med Sci, Sch Pharm, Dept Clin Pharm, Mashhad, Iran
[2] Jamia Hamdard, Sch Pharmaceut Educ & Res, Dept Pharmaceut, New Delhi, India
[3] Saveetha Inst Med & Tech Sci, Saveetha Dent Coll, Ctr Transdisciplinary Res, Dept Pharmacol, Chennai, India
[4] Univ Missouri Kansas City, Sch Pharm, Div Pharmacol & Pharmaceut Sci, Kansas City, MO USA
[5] Mashhad Univ Med Sci, Pharmaceut Technol Inst, Biotechnol Res Ctr, Mashhad, Iran
[6] Mashhad Univ Med Sci, Appl Biomed Res Ctr, Mashhad, Iran
[7] Mashhad Univ Med Sci, Sch Pharm, Dept Biotechnol, Mashhad, Iran
关键词
baicalein; capsaicin; coumarin; curcumin; cystic fibrosis; genistein; phytomedicine; quercetin; resveratrol; TRANSMEMBRANE CONDUCTANCE REGULATOR; NATURAL COMPOUND CURCUMIN; CHLORIDE-CHANNEL; WILD-TYPE; SURFACE EXPRESSION; NUCLEOTIDE-BINDING; DELTA-F508; CFTR; CELL-CULTURE; IN-VITRO; GENISTEIN;
D O I
10.1002/biof.1960
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The aim of this review was to review and discuss various phytochemicals that exhibit beneficial effects on mutated membrane channels, and hence, improve transmembrane conductance. These therapeutic phytochemicals may have the potential to decrease mortality and morbidity of CF patients. Four databases were searched using keywords. Relevant studies were identified, and related articles were separated. Google Scholar, as well as gray literature (i.e., information that is not produced by commercial publishers), were also checked for related articles to locate/identify additional studies. The relevant databases were searched a second time to ensure that recent studies were included. In conclusion, while curcumin, genistein, and resveratrol have demonstrated effectiveness in this regard, it should be emphasized that coumarins, quercetin, and other herbal medicines also have beneficial effects on transporter function, transmembrane conductivity, and overall channel activity. Additional in vitro and in vivo studies should be conducted on mutant CFTR to unequivocally define the mechanism by which phytochemicals alter transmembrane channel function/activity, since the results of the studies evaluated in this review have a high degree of heterogenicity and discrepancy. Finally, continued research be undertaken to clearly define the mechanism(s) of action and the therapeutic effects that therapeutic phytochemicals have on the symptoms observed in CF patients in an effort to reduce mortality and morbidity.
引用
收藏
页码:984 / 1009
页数:26
相关论文
共 50 条
  • [21] Cystic Fibrosis-Related Diabetes: Pathophysiology and Therapeutic Challenges
    Kelsey, Ryan
    Koivula, Fiona N. Manderson
    McClenaghan, Neville H.
    Kelly, Catriona
    CLINICAL MEDICINE INSIGHTS-ENDOCRINOLOGY AND DIABETES, 2019, 12
  • [22] Cyclic nucleotide phosphodiesterase inhibitors as therapeutic interventions for cystic fibrosis
    Turner, Mark J.
    Abbott-Banner, Kathy
    Thomas, David Y.
    Hanrahan, John W.
    PHARMACOLOGY & THERAPEUTICS, 2021, 224
  • [23] The Potential Causes of Cystic Fibrosis-Related Diabetes
    Coderre, Lise
    Debieche, Lyna
    Plourde, Joelle
    Rabasa-Lhoret, Remi
    Lesage, Sylvie
    FRONTIERS IN ENDOCRINOLOGY, 2021, 12
  • [24] Pathophysiology of Lung Disease and Wound Repair in Cystic Fibrosis
    Conese, Massimo
    Di Gioia, Sante
    PATHOPHYSIOLOGY, 2021, 28 (01) : 155 - 188
  • [25] Synthesis and Therapeutic Applications of Iminosugars in Cystic Fibrosis
    Esposito, Anna
    D'Alonzo, Daniele
    De Fenza, Maria
    De Gregorio, Eliana
    Tamanini, Anna
    Lippi, Giuseppe
    Dechecchi, Maria Cristina
    Guaragna, Annalisa
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (09)
  • [26] CFTR structure and cystic fibrosis
    Cant, Natasha
    Pollock, Naomi
    Ford, Robert C.
    INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2014, 52 : 15 - 25
  • [27] Novel therapeutic approaches for the management of cystic fibrosis
    Jaques, Ryan
    Shakeel, Arslan
    Hoyle, Cameron
    MULTIDISCIPLINARY RESPIRATORY MEDICINE, 2020, 15
  • [28] Protein Processing and Inflammatory Signaling in Cystic Fibrosis: Challenges and Therapeutic Strategies
    Belcher, C. N.
    Vij, N.
    CURRENT MOLECULAR MEDICINE, 2010, 10 (01) : 82 - 94
  • [29] Therapeutic update in cystic fibrosis
    Durupt, S.
    Josserand, R. Nove
    Durieu, I.
    REVUE DE MEDECINE INTERNE, 2014, 35 (06): : 388 - 392
  • [30] Therapeutic Potential of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Inhibitors in Polycystic Kidney Disease
    Li, Hongyu
    Sheppard, David N.
    BIODRUGS, 2009, 23 (04) : 203 - 216